D. Pizzuti

Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus.

L. Koss, K. Schreiber, Koss Lg, 1989, Journal of acquired immune deficiency syndromes.

Cardiovascular Risk in HIV Infection and Treatment A Roundtable Organized by the Forum for Collaborative HIV Research

D. Pizzuti, 2003 .

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

J. Leonard, J. Brunzell, J. Purnell, 2000, AIDS.

Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension.

O. Ben‐Yehuda, M. Littman, N. Henig, 2012, Journal of the American College of Cardiology.

Human Papillomavirus and Cardiovascular Disease

O. Ben‐Yehuda, M. Littman, N. Henig, 2012 .

A Phase I/II Study of the Protease Inhibitor Ritonavir in Children With Human Immunodeficiency Virus Infection

S. Steinberg, R. Nelson, A. Hsu, 1998, Pediatrics.

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir

A. D. Rodrigues, J. Leonard, A. Hsu, 1997, Antimicrobial agents and chemotherapy.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.

J. Moon, S. Childs, C. Cox, 1993, American Journal of Medicine.